Pharmacies excluded from preferred networks face much higher risk of closure
Study reveals how Medicare Part D networks managed by PBMs are contributing to widespread pharmacy closures.
Study reveals how Medicare Part D networks managed by PBMs are contributing to widespread pharmacy closures.
Bipartisan bill positions pharmacies as vital healthcare access points for seniors, driving solutions for healthier communities.
Awarded a $13,000 grant from the Cass County Opioid Settlement fund.
From metabolic disorders, to neurodegenerative, the chronic aspect of these conditions makes them the most prevalent in our society, and it seems that some mechanisms of action are common to most of them.
Ianniello has achieved significant successes with the help of SCORE, including renewing the company's entire staffing and pharmacy systems, opening a second location, building and technology updates, increased revenue threefold, and brokered a successful 340B collaboration with the local hospital.
The Future of Pharmacy Care Coalition urges Congress to pass the Ensuring Community Access to Pharmacist Services Act to ensure Medicare beneficiaries have access to essential care and services provided by pharmacists within state scope of practice laws.
Boyd's leadership and approach were instrumental in the development of NCPDP's new Strategic Plan, which continues to guide the organization's work to innovate, advocate, and collaborate across the healthcare industry.
Congress must act swiftly to finalize and pass robust pharmacy benefit manager reform legislation and push the Centers for Medicare & Medicaid Services to correct course on Medicare Drug Price Negotiation Program implementation.
PrimaryOne Health's retail and specialty pharmacy supports the Columbus, Ohio community with prescription management, home delivery, clinical counseling, health screenings, and more.
Wegovy will be the preferred GLP-1 medicine for obesity on the largest commercial template formularies for CVS Caremark, the largest Pharmacy Benefit Manager (PBM) in the US, effective July 1, 2025
Phenylephrine Hydrochloride Injection, USP is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
According to GlobalData’s report “Pharma M&A Trends – Q1 2025,” oncology remains the leading therapeutic area in Q1 2025, with most of the deals targeting cancer-related assets.
This tribute was particularly significant as Jim has been instrumental in constantly transforming and sustaining the NACDS Annual Meeting and other NACDS meetings and conferences as premier events that foster industry relationships and drive advancement.
This study compares the 50 states and the District in terms of 20 key metrics, ranging from arrest and overdose rates to opioid prescriptions and employee drug testing laws.
NASP opposes the legislation as passed by the Committee but commits to working with the bill sponsors, committee leadership and House leadership in an effort to address specialty pharmacy’s concerns.
Walgreens SVP and Chief Pharmacy Officer rallies the industry to modernize, collaborate, and advocate with “one voice” for the future of pharmacy care.